Cvs Health Stock News

CVS Health Corp (CVS) shares closed today at 0.9% below its 52 week high of $102.22, giving the company a market cap of $133B. The stock is currently up 52.1% year-to-date, up 52.8% over the past 12 months, and up 47.8% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 32.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -470.0% The company's stock price performance over the past 12 months beats the peer average by -401.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 118.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

CVS Health (NYSE:CVS) had its price objective increased by Tigress Financial from $108.00 to $122.00 in a research note released on Thursday morning, Analyst Ratings Network reports. They currently have a buy rating on the pharmacy operators stock. A number of other analysts have also recently weighed in on CVS. Morgan Stanley upped their target []

CVS Health Corp (CVS) shares closed today at 0.9% below its 52 week high of $102.22, giving the company a market cap of $133B. The stock is currently up 51.5% year-to-date, up 53.9% over the past 12 months, and up 47.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 34.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -453.5% The company's stock price performance over the past 12 months beats the peer average by -408.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 117.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Bay Colony Advisory Group Inc d b a Bay Colony Advisors lowered its stake in shares of CVS Health Co. (NYSE:CVS) by 2.0% in the third quarter, Holdings Channel reports. The firm owned 19,231 shares of the pharmacy operators stock after selling 392 shares during the period. Bay Colony Advisory Group Inc d b a []

Royal London Asset Management Ltd. lowered its position in CVS Health Co. (NYSE:CVS) by 0.6% during the third quarter, Holdings Channel reports. The institutional investor owned 471,144 shares of the pharmacy operator’s stock after selling 2,982 shares during the quarter. Royal London Asset Management Ltd.’s holdings in CVS Health were worth $39,965,000 as of its […]

What''s open on Christmas? For stores, CVS, Walgreens and convenience stores. For restaurants, select Starbucks, Dunkin'' and McDonald''s are open.

Amazon has announced a limit to the number of at-home Covid test kits per customer as demand surges amid a rise in cases since the discovery of the Omicron variant. Walgreens and CVS also introduced purchase limits. Read Full Article at RT.com

With the holidays approaching, omicron here, and case rates still high, tests are even harder to come by in Pennsylvania.

At-home COVID tests are flying off shelves and the two largest drugstore chains have responded with curbs on how many kits customers can buy at a time.

Decatur Capital Management Inc. purchased a new position in CVS Health Co. (NYSE:CVS) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 8,996 shares of the pharmacy operators stock, valued at approximately $763,000. A number of other institutional investors have also added to []

CVS Health Corporation (NYSE:CVS) traded at $100.85 at last check on Wednesday, December 22, made an upward move of 0.06% on its previous days price. Looking at the stock we see that its previous close was $100.79 and the beta (5Y monthly) reads 0.80 with the days price range being $100.42 $101.435. The company Why CVS Health Corporation Stock Might Make Sense If Bought Today Read More »

Walgreens and CVS previously imposed limits on COVID test kit purchases, both in-store and online, due to increased demand for at-home tests.

CVS said they''re added a limit of six kits per purchase to ensure enough people have access. Walgreens said it is limiting purchases to four at a time.

Amazon Limits Sales Of COVID Home Tests To 10 Per Person Looks like President Biden beat Amazon to the punch when he unveiled plans earlier this week that he would buy and distribute 500M COVID tests to Americans starting ASAP. The e-commerce giant has been so heavily inundated with orders for tests ahead of the holidays that it has opted to limit purchases of the at-home PCR tests kits to 10 units per shopper for the time being, according to CNBC . An Amazon spokesperson told CNBC that the company is experiencing inventory shortages on some Covid tests due to increased demand. The company is working to secure additional Covid test inventory from its selling partners, the spokesperson said. Well, we have some news for Amazon: it can try as hard as it wants to secure more tests, but President Biden''s latest purchase from the government might ultimately prove redundant since it''s looking increasingly likely that Americans and their insurance companies might have paid for them instead. With rising COVID case numbers in the US fueling the latest wave of holiday travel paranoia, pharmacy chains Walgreens and CVS Health also said Tuesday that they would limit how many at-home COVID tests customers can purchase both in-store and online.

Stockman Wealth Management Inc. boosted its position in shares of CVS Health Co. (NYSE:CVS) by 2.2% in the third quarter, Holdings Channel.com reports. The firm owned 78,217 shares of the pharmacy operator’s stock after acquiring an additional 1,667 shares during the period. CVS Health comprises approximately 1.5% of Stockman Wealth Management Inc.’s investment portfolio, making […]